AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 157.8% in April

AstraZeneca PLC (OTCMKTS:AZNCF) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 174,800 shares, a growth of 157.8% from the March 31st total of 67,800 shares. Based on an average daily volume of 2,200 shares, the days-to-cover ratio is presently 79.5 days.

AstraZeneca Stock Performance

AZNCF stock traded down $0.95 on Friday, reaching $145.10. The company’s stock had a trading volume of 55,915 shares, compared to its average volume of 3,606. AstraZeneca has a 52 week low of $118.16 and a 52 week high of $152.06. The firm has a fifty day moving average of $133.52 and a two-hundred day moving average of $131.07.

AstraZeneca Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, March 25th. Stockholders of record on Friday, February 23rd were issued a $1.97 dividend. The ex-dividend date of this dividend was Wednesday, February 21st. This is a positive change from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s dividend payout ratio is presently 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.